Recombinant porcine factor VIII use in bleed treatment in non-severe haemophilia A inhibitor patients: Dosing strategies and efficacy

被引：0
|
作者：
Ellsworth, Patrick [1 ,2 ]
Chen, Sheh-Li [3 ]
Key, Nigel [1 ]
Abajas, Yasmina [2 ]
Ma, Alice [1 ]
机构：
[1] Univ N Carolina, Dept Med, Div Hematol Oncol, Houpt Bldg,CB 7305,170 Manning Dr,3rd Floor, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Pediat, Div Pediat Hematol Oncol, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA
来源：
HAEMOPHILIA | 2021年 / 27卷 / 01期
关键词：
OBI-1; SEQUENCE; SAFETY;
D O I：
10.1111/hae.14111
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E147 / E150
页数：4
相关论文
共 50 条
  • [1] Recombinant Porcine Factor VIII Use in Bleed Treatment in Non-Severe Hemophilia a Inhibitor Patients: Dosing Strategies and Efficacy
    Ellsworth, Patrick
    Chen, Sheh-Li
    Abajas, Yasmina L.
    Moll, Stephan
    Key, Nigel S.
    Ma, Alice D.
    BLOOD, 2018, 132
  • [2] Continuous infusion of recombinant porcine factor VIII for neurosurgical management of intracranial haemorrhage in a patient with severe haemophilia A with factor VIII inhibitor
    Ruan, Gordon J.
    Mao, Jimmy J.
    Sytsma, Terin T.
    Akogyeram, Ivy I.
    Wang, Yucai
    Ashrani, Aneel A.
    Pruthi, Rajiv K.
    HAEMOPHILIA, 2020, 26 (03) : E141 - E144
  • [3] Factor VIII Levels in Blood Group O and Non-O in Patients with Non-Severe Haemophilia a
    Rejtoe, Judit
    Koenigsbruegge, Oliver
    Grilz, Ella
    Hofer, Stefanie
    Gebhart, Johanna
    Schuster, Gerhard
    Feistritzer, Clemens
    Quehenberger, Peter
    Ay, Cihan
    Pabinger, Ingrid
    BLOOD, 2019, 134
  • [4] The factor VIII treatment history of non-severe hemophilia A
    Abdi, Amal
    Kloosterman, Fabienne R.
    Eckhardt, Corien L.
    Male, Christoph
    Castaman, Giancarlo
    Fischer, Kathelijn
    Beckers, Erik A. M.
    Kruip, Marieke J. H. A.
    Peerlinck, Kathelijne
    Mancuso, Maria Elisa
    Santoro, Cristina
    Hay, Charles R.
    Platokouki, Helen
    van Der Bom, Johanna G.
    Gouw, Samantha C.
    Fijnvandraat, Karin
    Hart, Dan P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (12) : 3203 - 3210
  • [5] Inhibitor screening in non-severe haemophilia patients; a major challenge
    Hvas, Anne-Mette
    Poulsen, Lone H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (05) : 683 - 685
  • [6] Factor VIII inhibitors in patients with non-severe hemophilia
    Kempton, C. L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 78 - 79
  • [7] Treatment burden, haemostatic strategies and real world inhibitor screening practice in non-severe haemophilia A
    Batty, Paul
    Austin, Steve K.
    Khair, Kate
    Millar, Carolyn M.
    Palmer, Ben
    Rangarajan, Savita
    Stuempel, Jan-Phillip
    Thanigaikumar, Murugaiyan
    Yee, Thynn T.
    Hart, Daniel P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (05) : 796 - 804
  • [8] FACTOR VIII LEVELS IN BLOOD GROUP O AND NON-O IN NON-SEVERE HAEMOPHILIA A
    Rejto, J.
    Koenigsbruegge, O.
    Grilz, E.
    Hofer, S.
    Gebhart, J.
    Schuster, G.
    Feistritzer, C.
    Quehenberger, P.
    Ay, C.
    Pabinger, I.
    HAEMOPHILIA, 2020, 26 : 35 - 36
  • [9] Successful long-term treatment with porcine factor VIII of a patient with haemophilia A and an inhibitor to factor VIII
    Vyas, P
    Pasi, KJ
    Lee, CA
    HAEMOPHILIA, 1996, 2 (04) : 240 - 243
  • [10] Short term efficacy of recombinant porcine factor VIII in patients with factor VIII inhibitors
    Abou-Ismail, Mouhamed Yazan
    Vuyyala, Sowjanya
    Prunty, Jeremy
    Schmaier, Alvin H.
    Nayak, Lalitha
    HAEMOPHILIA, 2020, 26 (04) : 601 - 606
12345